**Advances in Spatial Transcriptomics: A New Era in Understanding Tissue Architecture**
Over the past few years, spatial transcriptomics has rapidly evolved from a nascent technology into a powerful and essential tool for unraveling the complex architecture of tissues. This innovative field allows researchers to simultaneously measure the gene expression of individual cells while preserving their precise physical locations within a tissue sample. The result is an unprecedented, high-resolution map of not just which genes are active, but *where* those activities occur, providing critical context for understanding development, disease, and the intricate interactions within the tumor microenvironment.
The foundation for this technological leap was laid by classical methods and early innovations. Foundational techniques like *in situ* hybridization paved the way, but the field truly began to accelerate with the introduction of more advanced platforms. Early methods included the use of polony gels for amplifiable DNA stamping and later, high-plex imaging technologies that combined RNA and protein detection at subcellular resolution. These were instrumental in proving the concept of multiplexed, spatially-resolved gene expression profiling in fixed tissues.
A major turning point came with the advent of **sequential hybridization** methods, such as Seq-Scope and the widely-used **Molecular Inverted Probe (MIP)**-based platforms. Seq-Scope enabled the first true “images” of the transcriptome at a genome-wide scale, while MIP methods offered a highly multiplexed and sensitive approach suitable for clinical samples. These innovations dramatically increased the number of genes that could be targeted simultaneously, transforming spatial transcriptomics from a proof-of-concept into a practical and scalable technology.
Recent years have seen an explosion in platform diversity and analytical sophistication. Novel approaches like **DNA nanoball-patterned arrays** now provide the throughput needed for whole-organism atlases, exemplified by the groundbreaking mouse organogenesis atlas. Other platforms, such as **sliding-clamp barcoding**, offer unique solutions for capturing full-length RNAs, further enriching the data obtained.
This technological maturation is reflected in the ambition of current research. The field is no longer just about mapping gene expression; it’s about **integrating** spatial data with other omics layers and using advanced computational methods to derive biological meaning. Researchers are now building comprehensive atlases of human development and disease, defining cellular neighborhoods within tumors, and deciphering cell-cell communication networks. For instance, studies of the gastric tumor microenvironment have moved beyond simple cell-type identification to reveal how specific cellular programs and interactions dictate patient outcomes and response to therapy.
The impact of these advances is profound. Spatial transcriptomics is providing a new lens through which to study development, offering a complete “parts list” of where and when genes are active in an embryo. In the clinic, it is revealing the hidden complexities of diseases like cancer, identifying immunosuppressive niches and pro-tumor cellular states that were previously invisible. As the technology continues to become more sensitive, multiplexed, and accessible, spatial transcriptomics is poised to become a standard tool in both research and diagnostic labs, fundamentally changing our understanding of biology and medicine.
***
**References**
1. Chen, A. et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. *Cell* **185**, 1777–1792 (2022).
2. Cho, C. S. et al. Microscopic examination of spatial transcriptome using Seq-Scope. *Cell* **184**, 3559–3572 (2021).
3. Fu, X. et al. Polony gels enable amplifiable DNA stamping and spatial transcriptomics of chronic pain. *Cell* **185**, 4621–4633 (2022).
4. He, S. et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. *Nat. Biotechnol.* **40**, 1794–1806 (2022).
5. Rao, A., Barkley, D., Franca, G. S. & Yanai, I. Exploring tissue architecture using spatial transcriptomics. *Nature* **596**, 211–220 (2021).
6. Bressan, D., Battistoni, G. & Hannon, G. J. The dawn of spatial omics. *Science* **381**, eabq4964 (2023).
7. Tian, L., Chen, F. & Macosko, E. Z. The expanding vistas of spatial transcriptomics. *Nat. Biotechnol.* **41**, 773–782 (2023).
8. Williams, C. G. et al. An introduction to spatial transcriptomics for biomedical research. *Genome Med.* **14**, 68 (2022).
9. Petukhov, V. et al. Cell segmentation in imaging-based spatial transcriptomics. *Nat. Biotechnol.* **40**, 345–354 (2022).
10. Chen, H., Li, D. & Bar-Joseph, Z. SCS: cell segmentation for high-resolution spatial transcriptomics. *Nat. Methods* **20**, 1237–1243 (2023).
11. Pachitariu, M. & Stringer, C. Cellpose 2.0: how to train your own model. *Nat. Methods* **19**, 1634–1641 (2022).
12. Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. *Nat. Methods* **18**, 100–106 (2021).
13. Ren, P. et al. Systematic benchmarking of high-throughput subcellular spatial transcriptomics platforms across human tumors. *Nat. Commun.* **16**, 9232 (2025).
14. Li, M. et al. CellBin: a highly accurate single-cell gene expression processing pipeline for high-resolution spatial transcriptomics. Preprint at bioRxiv (2024).
15. Palla, G. et al. Squidpy: a scalable framework for spatial omics analysis. *Nat. Methods* **19**, 171–178 (2022).
